Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tail-Engineered Phage P2 Enables Delivery of Antimicrobials into Multiple Gut Pathogens

2 Feb 2023

Abstract excerpt

High Resolution Image Download MS PowerPoint Slide Bacteriophages can be reprogrammed to deliver antimicrobials for therapeutic and biocontrol purposes and are a promising alternative treatment to antimicrobial-resistant bacteria. Here, we developed a bacteriophage P4 cosmid system for the delivery of a Cas9 antimicrobial into clinically relevant human gut pathogens Shigella flexneri and Escherichia coli O157:H7....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to CRISPR and Genetic Engineering
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36731126
DOI: 10.1021/acssynbio.2c00615

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tail-Engineered Phage P2 Enables Delivery of Antimicrobials into Multiple Gut PathogensPMID 36731126Read ↗

Engineering of Salmonella Phages into Novel Antimicrobial TailocinsSemantic proximity Read ↗

Pseudotyping Bacteriophage P2 Tail Fibers to Extend the Host Range for Biomedical ApplicationsSemantic proximity Read ↗

RNA and Single-Stranded DNA Phages: Unveiling the Promise from the Underexplored World of VirusesSemantic proximity Read ↗

Engineered Bacteriophages: Advances in Phage Genome Redesign Strategies for Therapeutic and Environmental ApplicationsSemantic proximity Read ↗

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 AntimicrobialsSemantic proximity Read ↗

Bacteriophages as Targeted Therapeutic Vehicles: Challenges and OpportunitiesSemantic proximity Read ↗

Armed Phages: A New Weapon in the Battle Against Antimicrobial ResistanceSemantic proximity Read ↗

Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular E. coli K1Semantic proximity Read ↗

Modification of T2 phage infectivity towardEscherichia coliO157:H7 via using CRISPR/Cas9Semantic proximity Read ↗

Bacteriophage ZCSE2 is a Potent Antimicrobial against Salmonella enterica Serovars: Ultrastructure, Genomics and EfficacySemantic proximity Read ↗

Phage Engineering for Targeted Multidrug-Resistant Escherichia coliSemantic proximity Read ↗

SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.